Cancer of the renal pelvis and ureter renal pelvis cancer, ureteral cancer
Conditions
Interventions
Upper urinary tract urine will be divided for this study in approximately 10 ml at the time of upper urine collection for patients for whom upper urinary cytology is deemed necessary for routine medic
D014556
urine
Sponsors
Hayakawa Nozomi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have visited the outpatient urology clinic, who are at least 20 years old, and whose urine can be collected.
Exclusion criteria
Exclusion criteria: 1) Patients undergoing treatment for malignant diseases in other departments 2) Patients who are judged by the investigator to be unsuitable as subjects 3) Patients who have indicated that they will not cooperate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exosomes extracted from urine samples will be analyzed using the ExoScreen method to evaluate differences in expression of specific exosomes between patients with renal pelvis or ureteral cancer and others. | — |
Secondary
| Measure | Time frame |
|---|---|
| In immunochemical staining of surgical specimens, the expression of target substances in cancer tissue, mainly nucleic acids and proteins including miRNAs in this study, will be compared with that in noncancer tissue. | — |
Contacts
Public ContactMiki Yoshiike
St. Marianna University School of Medicine
Outcome results
None listed